Table 1.
Participant characteristics
| Characteristic | Total sample (N=63) | |
|---|---|---|
| n | % | |
| Age, M (SD) | 43.6 (8.2) | |
| Years of education, M (SD) | 15.0 (4.3) | |
| Number of children, M (SD) | 2.4 (1.0) | |
| Age of children < 18, M (SD) | 11.6 (4.0) | |
| Months since metastatic diagnosis, M (SD) | 17 (18) | |
| Gender | ||
| Male | 20 | 31.7 |
| Female | 43 | 68.3 |
| Race/ethnicity | ||
| White, non-Hispanic | 47 | 74.6 |
| Black, non-Hispanic | 8 | 12.7 |
| Hispanic | 6 | 9.5 |
| Other | 8 | 12.7 |
| Marital status | ||
| Married/partnered | 42 | 66.7 |
| Single | 21 | 33.3 |
| Income | ||
| < $25,000 | 16 | 26.2 |
| $25,000 – 50,000 | 14 | 23.0 |
| $50,000 – 100,000 | 20 | 32.8 |
| > $100,000 | 11 | 18.0 |
| Antidepressant use* | ||
| Yes | 30 | 48.4 |
| No | 32 | 51.6 |
| Metastatic at diagnosis | ||
| Yes | 38 | 42.9 |
| No | 27 | 57.1 |
| Cancer site | ||
| Breast | 20 | 31.7 |
| Melanoma | 9 | 14.3 |
| Colon | 7 | 11.1 |
| Other gastro-intestinal | 7 | 11.1 |
| Genitourinary | 6 | 9.5 |
| Gynecologic | 5 | 7.9 |
| Other | 9 | 14.3 |
| ECOG performance status | ||
| 0 | 13 | 20.6 |
| 1 | 30 | 47.6 |
| 2 | 10 | 15.9 |
| 3–4 | 9 | 14.3 |
| Currently receiving treatment for metastatic illness |
||
| Yes | 56 | 88.9 |
| No | 7 | 11.1 |
Abbreviations: ECOG = Eastern Cooperative Oncology Group Performance Status
*
n = 62